Merck KGaA (MKGAF) News
Follow Merck KGaA (MKGAF) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 2 public stories across 2 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Qiagen M&A Fever Builds: KKR, EQT, Advent Explore Possible Takeover
Qiagen NV (NYSE: QGEN ) is drawing renewed investor attention after reports that several private equity firms are evaluating a potential takeover of the molecular diagnostics company. The stock surged 10.5% in the previo
MACRO | Jul 10, 2026, 01:26 PM UTC
H
Merck Buys Bio-Techne
Merck KGaA agrees to acquire Bio-Techne Corporation in an all-cash transaction valued at approximately $11.3 billion
EQUITY | Jun 25, 2026, 01:34 PM UTC